Fangyin Zeng
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 5
- Cancer, Lipids, and Metabolism 5
-
- Cancer Immunotherapy and Biomarkers 2
-
- Ferroptosis and cancer prognosis 4
- Prostate Cancer Treatment and Research 4
-
- Immune cells in cancer 2
-
- Epigenetics and DNA Methylation 3
-
- Cholesterol and Lipid Metabolism 2
- Cited by
- Cancer ResearchHepatologyOncology
- Journals
- Journal of Cell Science (1 paper)Journal of Clinical Microbiology (1 paper)Cellular and Molecular Life Sciences (1 paper)
- Partner nations
- ChinaUnited StatesJamaica
In The Last Decade
Fangyin Zeng
24 papers receiving 541 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 170
- Hepatology 41
- Oncology 133
- Pulmonary and Respiratory Medicine 151
- Immunology 92
Countries citing papers authored by Fangyin Zeng
This map shows the geographic impact of Fangyin Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangyin Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangyin Zeng more than expected).
Fields of papers citing papers by Fangyin Zeng
This network shows the impact of papers produced by Fangyin Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangyin Zeng. The network helps show where Fangyin Zeng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fangyin Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 69 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 6 | |
| 10 | 2021 | 7 | |
| 11 | 2020 | 72 | |
| 12 | 2020 | 36 | |
| 13 | 2020 | 10 | |
| 14 | 2019 | 44 | |
| 15 | 2019 | 27 | |
| 16 | 2018 | 29 | |
| 17 | 2014 | 11 | |
| 18 | [AXIN1-related CSRNP1 mRNA expression and its transcriptional regulation in TGF-β1-induced tumor cells]. | 2013 | 1 |
| 19 | 2012 | 72 | |
| 20 | 2011 | 57 |
About Fangyin Zeng
Fangyin Zeng is a scholar working on Cancer Research, Endocrinology and Otorhinolaryngology, having authored 25 papers that have together received 544 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Cancer, Lipids, and Metabolism (5 papers), Ferroptosis and cancer prognosis (4 papers), Prostate Cancer Treatment and Research (4 papers), Epigenetics and DNA Methylation (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cholesterol and Lipid Metabolism (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Cancer Research (170 citations), Hepatology (41 citations) and Oncology (133 citations). Fangyin Zeng has collaborated with scholars based in China, United States and Jamaica. Frequent co-authors include Fan Deng, Wanfu Xu, Guihuan Li, Qiming J. Wang, Hua Chen, Chunxia Wang, Hanyun Zhang, Zhiyong Ke, Zhipeng Zou and Songyu Li. Their work appears in journals such as Journal of Cell Science, Journal of Clinical Microbiology and Cellular and Molecular Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.